期刊文献+

乌司他丁预防小鼠术后腹腔粘连实验研究(英文) 被引量:7

PREVENTION OF POSTOPERATIVE PERITONEAL ADHESIONS BY ULINASTATIN IN MICE
下载PDF
导出
摘要 目的:研究乌司他丁预防小鼠术后腹腔粘连的能力。方法:以BALB/c小鼠为动物模型,经过一同一标准的腹膜损伤手术后,60只BALB/c小鼠随机分成两组:乌司他丁治疗组,生理盐水对照组,分别在关腹前腹腔内灌注乌司他丁及生理盐水。术后20d将小鼠处死,观察腹腔内粘连的情况,通过对粘连的程度、位置以及粘连类型的综合评价得出粘连分数。结果:乌司他丁治疗组的平均粘连分数(1.28±0.31)明显低于对照组(2.33±0.47),2-3级粘连发生率(23.3%)比对照组(76.7%)亦有明显减低(P<0.01)。无1例小鼠出现腹壁切口疝。结论:乌司他丁能够预防术后腹腔粘连形成,且对伤口愈合无明显影响。 Objective:To assess the ability of ulinastatin to prevent postoperative peritoneal adhesions formation in mice.Methods:60 BALB/c mice were randomly divided into two groups: ulinastatin group (n = 30) and control group (n= 30). After an identical peritoneal injury operation, mice were treated intraperitioneally with ulinastatin or saline at the time of abdominal closure. The mice were killed 20 days after operation, then the abdominal incisions and the development of intraabdominal adhesions were observed. Adhesion scoring was based on an overall assessment of the extent, location and adhesions type. Results: Ulinastatin group had significantly lower adhesion scores (1.28±0.31) than the control group (2.33±0.47). When two groups were analyzed for the presence of grade 2 -3 adhesions (advanced significant adhesions), the ulinastatin group had significantly lower incidence (23.3%) than control group (76. 7%). No incisional hernia was found in abdominal wall in all cases. Conclusions: The in-traperitoneal administration of ulinastatin could inhibit postoperative adhesion formation, and has no obviously side-effect on incision healing.
出处 《中国现代医学杂志》 CAS CSCD 2003年第19期55-57,共3页 China Journal of Modern Medicine
关键词 乌司他丁 腹膜粘连 疾病模型 Ulinastatin Peritoneal Adhesion Disease Models
  • 相关文献

参考文献9

  • 1Krahenbuhl L, Schafer M, Kuzinkovas V, et al. Experimental study of adhesion formation in open and lapaxcrscopic fundoplication.Br J Surg, 1998, 85(6) :826-830.
  • 2Pugia MJ, Takernura T, Kuwajima S, et al. Clinical utility of a rapid test for uristatin. Clin Biochem, 2002 , 35(2): 105-- 110.
  • 3Nakatani K, Takeshita S, Tsujimoto H, et al. Inhibitory effect of serine protease inhibitors on neutrophil - mediated endothelial cell injury. J Leukoc Biol,2001, 69(2): 241-247.
  • 4Kaidi AA, Gurchumelidze T, Nazzal NI, et al. Tumor necrosis factor - alpha: a marker for peritoneal adhesion formation. J Surg Res,1995, 58(5): 516-518.
  • 5Liakakos T, Thomakos N, Fine PM, et al. Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg, 2001 , 18(4) : 260--273.
  • 6Sato N, Endo S, Kimura Y, et al. Influence of a human protease inhibitor on surgical stress induced immunosuppression. Dig Surg,2002, 19(4): 300--305.
  • 7Lin SD, Endo R, Sato A, et al. Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis. J Gastroenterol Hepatol, 2002, 17(2) : 140-- 147.
  • 8Ambiru S, Miyazaki M, Sasada K, et al. Effects of perioparative protease inhibitor on inflammatory cytokines and acute- phase proteins in patients with hepatic resection. Dig Surg, 2000, 17(4) :337 - 343.
  • 9Nishlyama T, Hanaoka K. Hemolysis in stored red blood cell concentrates: modulation by haptoglobin or ulinastatin, a protease inhibitor. Crit Care Med, 2001 , 29(10) : 1979- 1982.

同被引文献26

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部